id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-1566-0003,FDA,FDA-2013-D-1566,"Naming of Drug Products Containing Salt Drug Substances; Guidance for
Industry; Availability",Notice,Notice of Availability,2015-06-17T04:00:00Z,2015,6,2015-06-17T04:00:00Z,,2015-06-17T16:06:45Z,2015-14884,0,0,0900006481b41339
FDA-2013-D-1566-0004,FDA,FDA-2013-D-1566,"Naming of Drug Products Containing Salt Drug Substances; Guidance for
Industry",Other,Guidance,2015-06-17T04:00:00Z,2015,6,2015-06-17T04:00:00Z,,2024-11-11T21:00:00Z,,1,0,0900006481b42503
FDA-2013-D-1566-0002,FDA,FDA-2013-D-1566,Draft Guidance for Industry on Naming of Drug Products Containing Salt Drug Substances,Other,Guidance,2013-12-26T05:00:00Z,2013,12,2013-12-26T05:00:00Z,,2024-11-07T23:00:18Z,,1,0,09000064814dcd46
FDA-2013-D-1566-0001,FDA,FDA-2013-D-1566,Draft Guidance for Industry on Naming of Drug Products Containing Salt Drug Substances; Availability,Notice,Notice of Availability,2013-12-26T05:00:00Z,2013,12,2013-12-26T05:00:00Z,2014-03-27T03:59:59Z,2014-03-27T01:02:38Z,2013-30800,0,0,09000064814dcb61